Download Citation
Article Source:
Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
Birkner B,
Rech J,
Stargardt T
(2020)
Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
PLOS ONE 15(1): e0226754.
https://doi.org/10.1371/journal.pone.0226754